Whether a buy and hold investment strategy is a good idea or not, is one of the most hotly debated investing concepts. From our point of view, the best answer as to whether buy and hold is a good ...

Independent regional clinical laboratory expects net income in the third quarter to be even with the prior year third quarter and hopes to see an improvement in fourth-quarter results over the prior ...

The Web cast will be archived, on both Web sites, for 30 days following the call. About Bio-Reference Laboratories, Inc. The Company is the largest independent regional clinical laboratory in the ...

A miss of Zacks estimates for Bio-Reference Laboratories (BRLI) led to sharp 11% decline, followed by moderate recovery punctuated with a 6 ¼ % decline May 4, to 32.99. Recent declines may be buying ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

ELMWOOD PARK, N.J.--(BUSINESS WIRE)--Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) executed a Restitution Agreement with John Littleton, a former vice president in sales. Pursuant to the Agreement ...

What: Marc D. Grodman, M.D., President and CEO of Bio-Reference Laboratories, Inc. (BRLI) will preside over the closing bell to celebrate the Company's 20th listing anniversary on NASDAQ. Where: ...

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. So What: ...

Uncrowned is a new destination for all things MMA, boxing, wrestling, and more, featuring Ariel Helwani. Yahoo Racing is powered by Motorsport Network, providing expert reporting, analysis, and ...

Bio-Reference Laboratories is up 81 cents, or 14.6 percent, to $6.37, after the Elmwood Park, N.J., firm reaffirmed its outlook for at least a 100 percent increase in pre-tax net income and a 20 ...